Background: Inflammatory bowel diseases (IBDs), Crohn's disease (CD) and ulcerative colitis (UC) are a group of chronic intestinal inflammatory conditions.
The exact cause of IBD remains unknown, but several theories have been proposed. Hygiene theory suggests that an alteration in the microbial environment of patients facilitates the evolution of chronic immune-mediated diseases and development of IBD. Recent studies showed that there is an increased incidence of IBD because of exogenous infections, use of antibiotics and diet. Medical treatment options have rapidly expanded in recent years.
Current medical therapy is facilitative and supportive rather than curative. The principles of medical treatment are approximately the same for ulcerative colitis and Crohn's disease. Treatment emphasizes, besides drugs, the individuality of the therapeutic response 5 .
Current disease management guidelines have therefore focused on the use of antiinflammatory agents, aminosalicylates, corticosteroids, immuno-modulators and more recently biological drugs in addition to surgery.
The aim of this study is to evaluate inflammatory bowel diseases in Bahrain.
METHOD
One hundred patients with IBD were reviewed, from July 2007 to January 2008. Data collected include: patients' characteristics (age, sex, nationality, occupation, age at diagnosis, duration of disease, smoking and family history of IBD), clinical presentation, endoscopic findings, histopathology, radiologic studies (abdominal ultrasound, Barium studies and abdominal CT studies), extent of disease, complications (intestinal and extra intestinal), exacerbations, hospital admission, associated medical diseases and treatment, medical or surgical.
RESULT
One hundred patients were reviewed. Patients' characteristics are shown in the table 1. Fiftyeight (58%) patients were 30-50 years old. IBD affected 55 (55%) females and 45 (45%) males. Eighty-five (85%) patients were Bahrainis. Forty-nine (49%) patients were not working. Most of the employed patients are semiskilled and 91 (91%) were indoor workers. The presenting symptoms were: 64 (64%) had diarrhea, 69 (69%) had gastrointestinal bleed and 57 (57%) had abdominal pain. Less common symptoms were: 8 (8%) had weight loss, 5 (5%) had perianal and anal symptoms, 4 (4%) had fever and 3 (3%) had dyspepsia, see table 3 and Figure 2 . Ninety-four (94%) patients had colonoscopy, 32 (32%) had esophagogastroduodenoscopy (OGD) and 18 (18%) had sigmoidoscopy. 
Figure 3: Extent of UC
Twelve (75%) of CD involved small and large bowels, 2 (12.5%) involved small bowel alone, one patient (6.25%) involved large bowel alone and one patient (6.25%) involved perianal area, see table 5 and figure 4. Forty-seven (47%) had intestinal bleeding, 14 (14%) had sepsis, 10 (10%) had polyps, 6 (6%) had fistula, 4 (4%) had stricture and 3 (3%) had obstruction. 
Figure 4: Extent of CD
Twelve (12%) patients had arthritis, 11 (11%) had skin lesions and 7 (7%) had anemia. Sclerosing cholangitis was seen in 2 (2%) patients and autoimmune hepatitis was seen in one patient (1%), see table 6 and figure 5. The average exacerbation of IBD was once per year in 27 (27%) patients, two exacerbations per year were seen in 13 (13%) patients, once in two years in 19 (19%) and once every 3 to 5 years in 20 (20%). Fifty-two (52%) patients required admission to hospital, see table 7. The following diseases were associated with IBD: diabetes Mellitus was found in 11 (11%) patients, hypertension in 10 (10%), G6PD deficiency in 6 (6%), sickle cell trait in 6 (6%), hyperlipidemia in 4 (4%), and sickle cell disease in one patient (1%), see table 8. Twenty-one (21%) patients were steroid dependent (steroid dependence was defined as a requirement for steroid therapy ≥ 10 mg/day during the preceding six months, with at least two attempts to discontinue the medication) 6 . Six (6%) patients had GI surgery, 3/6 patients (50%) had small bowel surgery, 3/6 patients (50%) had perianal surgery. Eight (8%) patients had endoscopic polypectomy.
The following drugs were used: Asacol (Mesalazine) in 83 (83%) patient, Imuran (Azathioprine) in 50 (50%), Steroid in 21 (21%), Asacol suppository in 17 (17%), Pentasa (Mesalazine) in 13 (13%), Infliximab in 8 (8%) and Folic acid in 71 (71%), see table 9. 
DISCUSSION
This study showed that age ranged 30 to 50 years, a mean of 40.69 years. A review study, the median age of onset of IBD was 35 years 7 . In another study, the age of patients showed biphasic distribution with two peaks between 20 and 30 and 50 and 70 years 8 .
In this study, females are affected more than males, for both types of IBD, UC and CD. Other studies showed that men and women at similar risk for UC. In CD, males are affected more than females, while in Western population females are affected more than males 7 . In a study in Lebanon, more males have been affected than females in CD (69.3%) and in UC (61.4%) 9 .
Fifty-one (51%) patients were employed; ninety-one (91%) were indoor workers. In a study, the mortality was higher in sedentary indoor workers compared to farmers and construction workers 10 . Sonnenberg suggested that employment involving outdoor air and physical activity is protective against IBD 11 .
In this study, the age at diagnosis of IBD was between 20-40 years, other studies showed that the peak age was 15-30 years old, although IBD can occur at any age 10 .
In this study, most patients were non-smoker; this is similar to other studies where smoking prevalence was significantly lower in UC patients than in general population (9% versus 28%) 12 .
In this study, the common presenting symptoms were Diarrhea, gastrointestinal bleed and abdominal pain, less common symptom was weight loss. The cardinal symptom of UC is bloody diarrhea; symptoms of colicky abdominal pain, urgency or tenesmus may be present. Symptoms of CD are more heterogenous, but typically include, abdominal pain, diarrhea and weight loss 13 .
In this study, the following investigative procedures were performed: colonoscopy 94 (94%), sigmoidoscopy 18 (18%) and histopathology 94 (94%). Compared with other studies diagnostic criteria were endoscopy, histopathology and radiology 14, 15 .
In this study, Forty-three (52.4%) of UC patients involved the left side of the colon, 33 (40.2%) had pancolitis, and 6 (7.3%) had distal colitis; our result is comparable with other studies 14 .
In this study, CD involved small and large bowel in 12 (75%), small bowel alone in 2 (12.5%), large bowel alone in one patient (6.25%) and perianal area in one patient (6.25%). Butt et al, in a study of CD showed that ileo-colonic disease affected 52%, ileal disease 24% and colonic 24% 16 .
Intestinal complications of IBD in this study were: forty-seven (47%) had intestinal bleeding, 14 (14%) had sepsis, 10 (10%) had polyps, 6 (6%) had fistula, 4 (4%) had stricture and 3 (3%) had obstruction. In a study of patients who had Crohn's disease, gastrointestinal complications particularly abdominal sepsis, intestinal ischemia, and intestinal hemorrhage accounted for the excess of mortality 17 . Twelve (12%) patients had arthritis, it was the most common extraintestinal complication seen in our study, 11 (11%) had skin lesions and 7 had (7%) anemia, compared with other studies, joints manifestations were the most common 18, 19 .
In our study, average exacerbation of IBD was once per year in 27 (27%) patients, while in another study relapses was seen in 32.9%, that study suggested that stressful life events do not trigger exacerbations in patients with IBD 20 . Elderly patients with IBD using mesalazine and corticosteroid lead to adverse effects including osteoporosis, bone fractures, changes in mental status, diabetes and hypertension 21 .
In this study, steroid dependency was seen in 21 (21%) patients with IBD, which is comparable to other studies 22, 23 . In patients with steroid dependency, it might be advisable to consider the use of biological agent (such as infliximab) for better control of IBD.
CONCLUSION
IBD affects females more than males. Eighty-two (82%) patients had Ulcerative Colitis, 16 (16%) had Crohn's disease and 2 (2%) were undetermined. Diarrhea, gastrointestinal bleed and abdominal pain were the most common presenting symptoms. More than half of the cases of UC involved left side of colon, while in CD, the majority of cases involved small and large bowels. 21 (21%) patients were steroid dependent. The most common drugs used was Asacol (Mesalazine), Imuran (Azathioprine) and Infliximab. This study is limited and does not reflect the whole problem of IBD in Bahrain. ___________________________________________________________________________
